NIH Funding Opportunities

Subscribe to NIH Funding Opportunities feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 8 min ago

Diversity Program Consortium Dissemination and Translation Awards (U01 - Clinical Trial Not Allowed)

Wed, 06/05/2019 - 09:41
Funding Opportunity RFA-RM-19-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from sites not currently part of the Common Fund Enhancing Diversity in the Biomedical Research Workforce initiative, also known as the Diversity Program Consortium (DPC), to expand the national impact of the program. The purpose is to provide funds to institutions to implement DPC scientific approaches to understanding the effectiveness of biomedical research training, mentoring or research capacity building interventions aimed at enhancing diversity in the biomedical research workforce.
Categories: Science RSS Feeds

NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

Wed, 06/05/2019 - 01:59
Funding Opportunity PAR-19-291 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigators. These non-tenure track scientists, such as researchers within a research program, are vital to sustaining the biomedical research enterprise. It is anticipated that only exceptional scientists who want to pursue research within the context of an existing NCI-funded cancer research program, but not serve as independent investigators, will be competitive for this award.
Categories: Science RSS Feeds

NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)

Wed, 06/05/2019 - 01:59
Funding Opportunity PAR-19-290 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigators. These scientists, such as researchers within a core/shared resource/central scientific support, are vital to sustaining the biomedical research enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others for career continuity.
Categories: Science RSS Feeds

Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)

Wed, 06/05/2019 - 00:28
Funding Opportunity RFA-AG-20-019 from the NIH Guide for Grants and Contracts. This FOA supports applications for Claude D. Pepper Older Americans Independence Centers (OAICs), centers of excellence in geriatrics research and research education to increase scientific knowledge leading to better ways to maintain or restore independence in older persons. The OAIC awards are designed to develop or strengthen awardee institutions programs that focus and sustain progress on a key area in aging research related to the mission of the OAIC program.
Categories: Science RSS Feeds

Advancing Novel Research Models to Study Idiopathic Pulmonary Fibrosis (U01 Clinical Trial Not Allowed)

Tue, 06/04/2019 - 00:04
Funding Opportunity RFA-HL-20-007 from the NIH Guide for Grants and Contracts. To establish a set of complementary model systems that reproduce essential disease-defining features of human idiopathic pulmonary fibrosis (IPF). This collection of models will advance our understanding of the pathogenesis of IPF from its onset through disease progression and serve as a resource for the broader research community, including investigators developing and testing novel therapies to treat this fatal disease.
Categories: Science RSS Feeds

Notice of Special Interest (NOSI): Leveraging existing HIV observational cohorts to study HIV-associated HLBS disorders

Mon, 06/03/2019 - 09:50
Notice NOT-HL-19-705 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Brain Initiative: Research to Develop and Validate Advanced Human Cell-Based Assays To Model Brain Structure and Function (R01 Clinical Trial Not Allowed)

Fri, 05/31/2019 - 11:28
Funding Opportunity RFA-MH-20-140 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward developing next-generation human cell-derived assays that replicate complex nervous system architectures and physiology with improved fidelity over current capabilities. This includes technologies that do not rely on the use of human fetal tissue, as described in NOT-19-042. Supported projects will be expected to enable future studies of complex nervous system development, function and aging in healthy and disease states.
Categories: Science RSS Feeds

National Drug Early Warning System Coordinating Center (U01 Clinical Trial Optional )

Fri, 05/31/2019 - 10:48
Funding Opportunity RFA-DA-20-016 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications for a single Coordinating Center to support novel data acquisition strategies, data harmonization, analysis and dissemination activities on emerging and current drug abuse trends across the United States. The Coordinating Center will (1) Maintain a Scientific Advisory Group; (2) Maintain and refine an Early Warning Network composed of local experts on drug abuse data from the selected communities, as well as NIDA-supported community-based researchers, to assist in the ongoing monitoring and interpretation of data; (3) Maintain key community-level indicators for monitoring drug abuse trends and early identification of new synthetic drugs and emerging issues including establishing harmonization of indicators and of presentation and analysis of indicators across the selected communities; (4) Continue to identify and maintain novel sources of data including treatment admissions data, national drug use among adults and youth, law enforcement seizures, and drug poisoning death; (5) Conduct cross-site data analyses from the harmonized Coordinating Center data; (6) Continue to disseminate and identify novel ways to execute dissemination and publication plans of results and findings from the Coordinating Center data, including development and maintenance of a website for disseminating data and findings; (7) Conduct webinars on topics of interest to stakeholders; (8) Conduct on the ground epidemiologic investigations on topics of immediate crisis or need, providing functional feedback to impacted communities towards optimizing current and future response; (9) Provide operational, administrative and logistical support for the Coordinating Center data harmonization and dissemination initiative.
Categories: Science RSS Feeds

Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)

Thu, 05/30/2019 - 11:40
Funding Opportunity RFA-AI-19-042 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from institutions to participate in the Immunobiology of Xenotransplantation Cooperative Research Program (IXCRP), for the development of preclinical porcine-to-nonhuman primate (NHP) models of pancreatic islet, kidney, heart, lung, or liver xenotransplantation. The goals of this program are to: (1) delineate the cellular and molecular mechanisms of xenograft rejection and/or the induction of immune tolerance; (2) develop effective strategies to improve xenograft survival; and (3) characterize and address the physiological compatibility/limitations of xenografts. The long-term goal of this program is to develop strategies for application of xenotransplantation in the clinic.
Categories: Science RSS Feeds

Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)

Thu, 05/30/2019 - 11:40
Funding Opportunity RFA-AI-19-043 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from institutions to participate in the Immunobiology of Xenotransplantation Cooperative Research Program (IXCRP), for the development of preclinical porcine-to-nonhuman primate (NHP) models of pancreatic islet, kidney, heart, lung, or liver xenotransplantation. The goals of this program are to: (1) delineate the cellular and molecular mechanisms of xenograft rejection and/or the induction of immune tolerance; (2) develop effective strategies to improve xenograft survival; and (3) characterize and address the physiological compatibility/limitations of xenografts. The long-term goal of this program is to develop strategies for application of xenotransplantation in the clinic.
Categories: Science RSS Feeds

Exploratory Grant for NIA Alzheimers Disease Research Center (P20 Clinical Trial Not Allowed)

Thu, 05/30/2019 - 10:28
Funding Opportunity RFA-AG-20-023 from the NIH Guide for Grants and Contracts. This funding opportunity announcement invites applications to plan and initiate collaborative activities that will develop and implement infrastructure appropriate for an Alzheimer's Disease Research Center (P30).
Categories: Science RSS Feeds

Exploiting In Vivo Precision Pharmacology Techniques to Understand Opioid Receptor Signaling in Specific Circuits, Cell Types, and Subcellular Compartments (R61/R33 - Clinical Trial Not Allowed)

Thu, 05/30/2019 - 10:00
Funding Opportunity RFA-DA-20-019 from the NIH Guide for Grants and Contracts. This funding opportunity aims to support the development and the application of novel pharmacological approaches to manipulate signaling mediated by endogenous opioid receptors in defined circuits, cell-types or subcellular compartments in live organisms.
Categories: Science RSS Feeds

Oscillatory Patterns of Gene Expression in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)

Thu, 05/30/2019 - 07:15
Funding Opportunity RFA-AG-20-040 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that seek to enhance existing transcriptome and proteome data sets by revealing oscillatory patterns of gene expression in aging and in Alzheimer's disease (AD), by uncovering their molecular significance, and by identifying rhythmic gene and/or protein profiles associated with the risk for AD.
Categories: Science RSS Feeds

Notice of Special Interest for Small Business in Genomic Medicine Research

Thu, 05/30/2019 - 07:08
Notice NOT-HG-19-021 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Adipogenesis, Adipocyte Function and Obesity Following HIV Infection, Antiretroviral Therapy, or Pre-Exposure Prophylaxis (R01 Clinical Trial Optional)

Wed, 05/29/2019 - 10:50
Funding Opportunity RFA-DK-19-008 from the NIH Guide for Grants and Contracts. The prevalence of obesity is increasing in people with HIV (PWH), contributing to multiple complications associated with this condition. There is mounting evidence that there are unique mechanisms contributing to the development of obesity in PWH versus people without HIV. Furthermore, the biology of the adipocytes might be altered in overweight or obese PWH versus overweight or obese people without HIV. This FOA seeks applications to elucidate the underlying mechanisms of how HIV and antiretroviral drugs used for therapy or pre-exposure prophylaxis contribute to the development of obesity and alter adipocyte and adipose tissue function as well as the effects of these processes on metabolic and physiological processes within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Categories: Science RSS Feeds

Pages